Media stories about PerkinElmer (NYSE:PKI) have been trending somewhat positive recently, AlphaOne reports. AlphaOne, a unit of Accern, ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources. AlphaOne ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. PerkinElmer earned a media sentiment score of 0.15 on AlphaOne’s scale. AlphaOne also assigned news articles about the medical research company an impact score of 67 out of 100, meaning that recent media coverage is likely to have an impact on the company’s share price in the next few days.
PerkinElmer (NYSE:PKI) last posted its quarterly earnings data on Thursday, May 4th. The medical research company reported $0.55 EPS for the quarter, beating the Zacks’ consensus estimate of $0.54 by $0.01. PerkinElmer had a net margin of 10.52% and a return on equity of 14.26%. The company had revenue of $514.12 million during the quarter, compared to the consensus estimate of $506.81 million. During the same quarter in the prior year, the company posted $0.50 EPS. The company’s quarterly revenue was up 3.2% compared to the same quarter last year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, August 10th. Stockholders of record on Friday, July 21st will be paid a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.45%. The ex-dividend date is Wednesday, July 19th. PerkinElmer’s dividend payout ratio is currently 13.15%.
Several research firms have weighed in on PKI. Barclays PLC set a $55.00 price target on shares of PerkinElmer and gave the stock a “sell” rating in a research report on Saturday, May 6th. Cantor Fitzgerald reiterated a “hold” rating and issued a $65.00 price target on shares of PerkinElmer in a research report on Monday. Jefferies Group LLC reiterated a “hold” rating and issued a $49.00 price target on shares of PerkinElmer in a research report on Monday. Citigroup Inc increased their price target on shares of PerkinElmer from $57.00 to $67.00 and gave the stock a “buy” rating in a research report on Friday, April 7th. Finally, Zacks Investment Research upgraded shares of PerkinElmer from a “sell” rating to a “hold” rating in a research report on Friday, March 10th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company’s stock. PerkinElmer has an average rating of “Hold” and a consensus price target of $57.30.
ILLEGAL ACTIVITY NOTICE: “PerkinElmer (PKI) Given Daily News Sentiment Rating of 0.15” was published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The original version of this piece of content can be accessed at https://www.chaffeybreeze.com/2017/05/19/perkinelmer-pki-receives-daily-media-impact-rating-of-0-15-updated-updated.html.
In other news, insider Joel S. Goldberg sold 30,710 shares of the business’s stock in a transaction dated Monday, March 13th. The stock was sold at an average price of $55.45, for a total transaction of $1,702,869.50. Following the completion of the sale, the insider now owns 91,768 shares in the company, valued at approximately $5,088,535.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Patrick J. Sullivan sold 6,628 shares of the business’s stock in a transaction dated Monday, May 15th. The stock was sold at an average price of $62.59, for a total value of $414,846.52. Following the sale, the director now owns 42,951 shares of the company’s stock, valued at approximately $2,688,303.09. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 198,583 shares of company stock valued at $11,761,403. Corporate insiders own 2.30% of the company’s stock.
PerkinElmer Company Profile
PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.
Receive News & Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.